These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18004453)

  • 1. Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments.
    Tanabe K; Zhang Z; Ito T; Hatta H; Nishimoto S
    Org Biomol Chem; 2007 Dec; 5(23):3745-57. PubMed ID: 18004453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular design of hypoxic tumor cell-targeting drugs and imaging probes].
    Tanabe K; Ito T; Nishimoto S
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1588-93. PubMed ID: 18051384
    [No Abstract]   [Full Text] [Related]  

  • 3. Design of anticancer prodrugs for reductive activation.
    Chen Y; Hu L
    Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.
    Tranoy-Opalinski I; Legigan T; Barat R; Clarhaut J; Thomas M; Renoux B; Papot S
    Eur J Med Chem; 2014 Mar; 74():302-13. PubMed ID: 24480360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What "helps" tumors evade vascular targeting treatment?
    Si ZC; Liu J
    Chin Med J (Engl); 2008 May; 121(9):844-9. PubMed ID: 18701052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular disrupting agents.
    Lippert JW
    Bioorg Med Chem; 2007 Jan; 15(2):605-15. PubMed ID: 17070061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provascular strategy: targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment.
    Sonveaux P
    Radiother Oncol; 2008 Mar; 86(3):300-13. PubMed ID: 18313779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new probe for targeting drug delivery system.
    Yu Z; Wang B; Sui J; Feng Y; Zheng C
    Med Hypotheses; 2009 Jan; 72(1):43-4. PubMed ID: 18829175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a case for selectively promiscuous anticancer drugs?
    Fernández A; Crespo A; Tiwari A
    Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies on the development of small molecule anticancer drugs for targeted therapy.
    Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
    Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular-targeted therapy for malignant glioma].
    Yamanaka R
    Brain Nerve; 2009 Feb; 61(2):177-88. PubMed ID: 19235468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of in vivo imaging system targeting a molecular marker].
    Furukawa T
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1269-71. PubMed ID: 18701835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
    Gindy ME; Prud'homme RK
    Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.
    Tietze LF; Krewer B
    Chem Biol Drug Des; 2009 Sep; 74(3):205-11. PubMed ID: 19660031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.